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1 
Abstract 
A personal UV dosimeter that can quantitatively assess high exposure solar UVA 
exposures has been developed. The chemical polyphenylene oxide has been previously 
reported on its ability to measure high UVB exposures. This current research has found 
that polyphenylene oxide, cast in thin film form, is responsive to both the UVA and UVB 
parts of the solar spectrum. Further to this, the UVB wavelengths were filtered out with 
the use of mylar. This combined system responded to the UVA wavelengths only and 
underwent a change in optical absorbance as a result of UVA exposure. Preliminary 
results indicate that this UVA dosimeter saturates steadily when exposed to sunlight and 
can measure exposures of more than 20 MJ/m2 of solar UVA radiation with an 
uncertainty level of no more than ± 5%. 
 
 
1 Introduction 
Exposure to UV radiation is known to be a causative factor in the induction of skin 
cancers and other sun-related disorders. Most acute responses of humans to UV exposure 
occur as a result of UVB (280 to 315 nm) exposures, as these wavelengths are highly 
effective in creating a human biological response. However, this does not mean that UVA 
radiation has no impact on human UV exposures and health. UVA can cause erythema in 
human skin, yet, the exposures required to create such a response is much larger than 
UVB radiation. UVA radiation penetrates much deeper into human skin tissue than UVB, 
resulting in impacts that are not as acute, taking many years to manifest. Past research has 
shown that UVA (315 to 400 nm) plays a significant role in human skin carcinogenesis, 
immune suppression, DNA damage, photoageing and wrinkling (Agar et al., 2004; Moan 
et al., 1999; Garland et al., 2003). Skin cancer is considered the most common malignant 
neoplasm in Australia and the USA (Kricker and Armstrong, 1996; Glanz and Mayer, 
2005; NCI, 2006). Over 1,600 Australians die from skin cancer each year and a further 
380,000 Australians are treated for skin cancer each year (NCCI, 2003; AIHW, 2004; 
AIHW, 2005). Skin cancer is Australia’s most expensive cancer with estimated amounts 
of $264 million and $30 million spent in Australia during 2001 on NMSC and melanoma 
respectively (AIHW, 2005). As a result, it is essential to decrease the amount of exposure 
to damaging solar UV radiation that the population experiences. This requires methods to 
understand the solar UV radiation environment that humans live in. Spectroradiometers, 
broadband meters and dosimeters are often utilised for the measurement of incident solar 
UV radiation. Quantification of the individual level of solar UV radiation exposure 
requires personal dosimetry due to changes in the position of people compared to the 
radiation source. Dosimetry is very useful as researchers can leave the dosimeters in situ 
for extended periods of time to monitor long term UV trends. However, dosimeters need 
to be calibrated against a spectroradiometer or broadband meter. On the other hand, 
spectroradiometers and broadband meters are more useful for analysing the effect of 
changing atmospheric variables (e.g. clouds, aerosols and ozone) upon UV dosages.  
 
Commonly used UV chemical dosimeters are polysulphone and phenothiazine. 
Phenothiazine has been used for measuring UVA wavelengths in various environments 
(Parisi et al., 2005). However, phenothiazine only has the capability to record a 
cumulative exposure over a small time period, usually three to four hours. This small 
2 
dynamic range greatly reduces the amount of time over which a UVA exposure can be 
measured in the field. Therefore, a chemical dosimeter that is capable of measuring large 
amounts of UVA radiation over a long time period would be very useful. Research 
conducted by Davis et al. (1976) showed that Poly (2,6-dimethyl-1, 4-phenylene oxide) 
(PPO) film could be employed to measure high levels of UV exposure. Further research 
found PPO to be ideal for this purpose as it would allow for unattended UVB 
measurements to be made at various locations over a time period of at least one week 
with high levels of accuracy when compared against radiometric measurements (Davis et 
al., 1981; Berre and Lala, 1989; Lester et al., 2003). Schouten et al. (2007) found that 
PPO has a progressively increasing response to UVA wavelengths over time. PPO 
dosimeters have been utilised in the measurement of global UVB and erythemal 
exposures, however, they have not been used to measure solar UVA exposures. The aim 
of this paper was to extend the previous research that has employed PPO dosimeters for 
the measurement of solar UVB and erythemal exposures to investigate the suitability of 
PPO for the measurement of high exposure solar UVA irradiances. 
 
 
2 Materials and Methods 
 
2.1 PPO 
PPO film of approximately 40 µm thickness was attached with adhesive tape to a plastic 
holder. The holders for the dosimeters were 3 x 3 cm in area and fabricated from thin 
polyvinylchloride with an aperture of approximately 1.2 x 1.6 cm (Figure 1). A 
UV/visible spectrophotometer (model 1601, Shimadzu Co., Kyoto, Japan) was used to 
measure the pre and post exposure absorbance of the dosimeter. The uncertainty range for 
optical absorbance measurements in the spectrophotometer has been stated as ± 0.002 by 
the manufacturer. PPO is responsive to both the UVA and UVB part of the solar 
spectrum, therefore the UVB wavelengths were filtered by placing 120 μm thick mylar 
film (Cadillac Plastics, Australia) on top of the PPO film. For each dosimeter, the change 
in optical absorbance (ΔA320) due to UV exposure was measured at 320nm (with mylar 
removed) at four different sites over the dosimeter in order to minimise any errors due to 
any possible minor variations in the PPO film over the size of the dosimeter. The change 
in optical absorbance was measured at 320 nm as previous studies have shown that this is 
the wavelength where the greatest overall UV energy induced change occurs (Lester et 
al., 2003; Schouten et al., 2007). The post exposure absorbance was measured at a 
standardized time following exposure to minimize any error associated with the post 
exposure ‘dark reaction’ of the PPO (Lester et al., 2003; Schouten et al., 2007). Lester et 
al. (2003) has shown previously that the PPO dosimeter is not a temperature dependent 
system, so fluctuations in temperature over the exposure time period will not have any 
influence upon the subsequent measurement error. 
  
2.2 Calibration  
The dosimeters were calibrated for UVA exposures by exposing a series of dosimeters on 
a horizontal plane, to relatively clear sky solar UV from approximately 0800 to 1600 h 
Australian Eastern Standard Time (EST) for a total of 22 days. One dosimeter was 
removed from solar exposure at regular periods of time ranging from one to two days 
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with the last dosimeter being removed after 22 days. The dosimeters were brought in at 
the end of each day to ensure that they did not receive any overnight damage. These 
calibrations ran over the months of April and May at a subtropical Southern Hemisphere 
site at the University of Southern Queensland, Toowoomba, Australia (27.6oS, 151.9oE, 
altitude 693 m). The solar zenith angle (SZA) ranged from 30o to 75o. The PPO 
dosimeters were calibrated on a horizontal plane with a UVA meter (501 UVA Biometer, 
Solar Light Co., Philadelphia, USA). The UVA meter was calibrated against a scanning 
spectroradiometer (Bentham Instruments, Ltd, Reading, UK). The spectroradiometer is 
based on a double grating monochromator, a UV sensitive detector and amplifier with 
software variable gain provided by a programmable high voltage power supply. The 
container in which the spectroradiometer is housed is temperature stabilised with a Peltier 
system and the temperature set to 25 oC. The temperature inside the container at each 
scan is recorded by the software. For the times that the temperature inside the container 
housing the spectroradiometer varied by more than 1 oC from the set temperature due to 
hot ambient temperatures, the manufacturer supplied temperature correction factor of -
0.4%/oC was applied in the post processing to the spectral irradiance data collected at 
each 0.5 nm increment. This correction was the same at all wavelengths. The wavelength 
shift of the instrument due to temperature as provided by the manufacturer is 0.005 
nm/oC. Consequently, any wavelength shift was minimal and no correction for 
wavelength shift has been applied. The input optics of the spectroradiometer are provided 
by a PTFE (polytetrafluoro ethylene) diffuser and connected by an optical fibre to the 
input slit of the monochromator. The spectroradiometer is programmed to start scanning 
the global UV spectrum from 280 to 400 nm in 0.5 nm increments from dawn, and 
thereafter every 10 minutes till dusk. The instrument is wavelength calibrated to the UV 
spectral lines of a mercury lamp and irradiance calibrated to a 150 Watt quartz tungsten 
halogen lamp with calibration traceable to the National Physical Laboratory, UK 
standard.  
 
To produce the calibration curve, the UVA exposure (MJ/m2) was measured over specific 
intervals with the UVA meter. This measurement was then calibrated to the scanning 
spectroradiometer by employing a transfer equation with a calculated R2 value of no less 
than 0.99. After each interval, the ΔA320 for a single PPO dosimeter was measured by the 
spectrophotometer to provide a single data point, where ΔA320 was calculated by the 
following 
INITIALFINAL AAA 320320320 −=Δ   (1) 
where  is the final optical absorbance measurement after exposure taken at 320 nm 
and  is the initial absorbance measurement before exposure taken at 320 nm. After 
the absorbency was measured, the dosimeter was then removed from the batch. 
FINALA320
INITIALA320
 
2.3 Reproducibility 
To test the reproducibility of the dosimeters for the measurement of solar UVA, ten 
dosimeters (with mylar filter) were exposed simultaneously to solar UV over a three hour 
period on a horizontal plane. These exposures were conducted on an unshaded sports oval 
in autumn under clear sky conditions to ensure that the dosimeters were exposed to all of 
the incident solar UV radiation, both direct and diffuse radiation from the sky.  
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3 Results 
 
3.1 Filtered Exposures 
The spectral transmission of the mylar film was measured pre-exposure and post-
exposure to solar UV to test for any significant changes. The change in spectral 
transmission of the mylar film is provided in Figure 2. The maximum change was 
approximately 13% from 331 to 337 nm. The change in absorbency of the PPO film pre- 
and post-exposure is provided in Figure 3. 
 
3.2 Calibration 
The calibration of the PPO dosimeters for solar UVA exposure is shown in Figure 4. The 
data points are the averages of the four ΔA’s measured for each dosimeter and the error 
bars on the x-axis values are the standard deviation of the four measurements. A power 
law was fitted to the calibration data with the form of: 
 
UVA = 11.7(x0.51) MJ/m2  (2) 
 
where x is the change in absorbency. The resulting R2 for the calibration was greater than 
0.99.  
 
3.3 Reproducibility  
For the reproducibility tests, all dosimeters received the same exposure of solar UV 
producing a mean ΔA320 of 0.598 with a standard deviation of no more than 3% and a 
coefficient of variation equal to approximately 5%. This variation may be due to minor 
variations over the surface of the sheet of PPO film, from which the dosimeters were 
fabricated, that are inherent in the casting process and are difficult to eliminate. Variation 
can also be influenced by dust particles that may have accumulated on the surface of the 
dosimeters during the exposure period. 
 
 
4 Discussion 
PPO film has never before been used to measure solar UVA exposures, however, 
preliminary results indicate that this UVA dosimeter saturates reasonably slowly when 
exposed to sunlight and can measure exposures of more than 20 MJ/m2 of solar UVA 
radiation with an uncertainty level of no more than ± 5%. For the Toowoomba 
measurement site, this equates to approximately two weeks of full day UVA exposures 
under clear sky conditions. This exposure period will be extended for higher latitude sites 
and also for varying atmospheric conditions.  
 
The size and lightweight properties of the dosimeter means that it can be attached to any 
anatomical site on the human body in different environments such as underneath shade or 
in a vehicle in order to measure the solar UVA exposures with a level of ease, simplicity 
and cost-effectiveness not associated with counterpart radiometric measurements. The 
usage of the dosimeter requires the calibration against a calibrated UVA meter. The 
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profile of the calibration curve will vary with the season and this can be overcome by 
calibrating the dosimeter in the season that it will be employed to measure the solar UVA 
exposures. Schouten et al (2008) found that when the PPO dosimeter is calibrated to 
UVB wavelengths over different seasons there was a slight but definite variation between 
calibration profiles. However, when PPO is calibrated to UVA wavelengths this variation 
will be significantly reduced due to the fact that UVA wavelengths are not affected by 
atmospheric parameters to the extent that UVB wavelengths are. 
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Figure Captions 
 
Figure 1. A sample PPO dosimeter with the mylar film attachment. 
 
Figure 2. The spectral transmission of mylar film before and after a total solar UVA 
exposure of 20 MJ/m2. 
 
Figure 3. The absorption spectrum of PPO before and after a total solar UVA exposure 
of 20 MJ/m2. 
 
Figure 4. Calibration curve of PPO for UVA exposures. The error bars represent the 
standard deviation in each series of absorbency measurements.  
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Figure 1. A sample PPO dosimeter with the mylar film attachment. 
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Figure 2. The spectral transmission of mylar film before and after a total solar UVA 
exposure of 20 MJ/m2. 
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Figure 3. The absorption spectrum of PPO before and after a total solar UVA exposure 
of 20 MJ/m2.  
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Figure 4. Calibration curve of PPO for solar UVA exposures. The error bars represent 
the standard deviation in each series of absorbency measurements.  
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